<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04227392</url>
  </required_header>
  <id_info>
    <org_study_id>E-1801-444-001</org_study_id>
    <nct_id>NCT04227392</nct_id>
  </id_info>
  <brief_title>Effect of Vaginal Radiofrequency Therapy on Vaginal Laxity : Pilot Trial</brief_title>
  <acronym>ROSE</acronym>
  <official_title>Effect of Vaginal Radiofrequency Therapy on Vaginal Laxity : Pilot Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To examine the efficacy and safety of radiofrequency therapy on vaginal laxity, The
      investigators enrolled 30 women with vaginal laxity. Radiofrequency therapy was consisted of
      2 sessions with 3 week interval. A session included 20 minutes radiofrequency therapy on
      vaginal mucosa. Vaginal laxity score, female sexual function index (FSFI), female sexual
      distress scale (FSDS), vaginal pressure, adverse events were examined. Follow up period is 3
      months.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2018</start_date>
  <completion_date type="Actual">May 31, 2019</completion_date>
  <primary_completion_date type="Actual">January 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change of vaginal laxity score from baseline</measure>
    <time_frame>baseline - at 2nd therapy session (3week from baseline) - 1 month from 2nd therapy session - 3 month from 2nd therapy session</time_frame>
    <description>subjective vaginal laxity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change of FSFI score from baseline</measure>
    <time_frame>baseline - 1 month from 2nd therapy session - 3 month from 2nd therapy session</time_frame>
    <description>female sexual function index, higher is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change of FSDS score from baseline</measure>
    <time_frame>baseline - 1 month from 2nd therapy session - 3 month from 2nd therapy session</time_frame>
    <description>female sexual distress scale, lower is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change of vaginal pressure from baseline</measure>
    <time_frame>baseline - at 2nd therapy session (3week from baseline) - 1 month from 2nd therapy session - 3 month from 2nd therapy session</time_frame>
    <description>vaginal pressure measured with manometer</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Vaginal Laxity</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>women who undergo radiofrequency therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>vaginal radiofrequency</intervention_name>
    <description>2 sessions of vaginal radiofrequency therapy with 3 week interval. A session last 20 minutes.</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  vaginal laxity score &gt;= 3

          -  negative pregnancy test within 2 months

        Exclusion Criteria:

          -  genital anomaly

          -  pelvic prolapse stage &gt;= stage 3

          -  active genital infection

          -  vulvar pain or deformity

          -  disease related to sexual behavior

          -  current, chronic NSAIDs intake

          -  fever

          -  any acute illness

          -  cognitive disorder

          -  pacemaker insertion

          -  metal implants
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam Si</city>
        <state>Gyenggi DO</state>
        <zip>463707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>January 1, 2020</study_first_submitted>
  <study_first_submitted_qc>January 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 13, 2020</study_first_posted>
  <last_update_submitted>January 9, 2020</last_update_submitted>
  <last_update_submitted_qc>January 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

